114 related articles for article (PubMed ID: 9397576)
1. The berenil ligand directs the DNA binding of the cytotoxic drug Pt-berenil.
González VM; Pérez JM; Alonso C
J Inorg Biochem; 1997 Dec; 68(4):283-7. PubMed ID: 9397576
[TBL] [Abstract][Full Text] [Related]
2. The formation of DNA interstrand cross-links by a novel bis-[Pt2Cl4(diminazene aceturate)2]Cl4.4H2O complex inhibits the B to Z transition.
González VM; Fuertes MA; Jiménez-Ruíz A; Alonso C; Pérez JM
Mol Pharmacol; 1999 Apr; 55(4):770-7. PubMed ID: 10101036
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and DNA modification induced by a novel Pt-berenil compound with cytotoxic activity.
González VM; Amo-Ochoa P; Pérez JM; Fuertes MA; Masaguer JR; Navarro-Ranninger C; Alonso C
J Inorg Biochem; 1996 Jul; 63(1):57-68. PubMed ID: 8699173
[TBL] [Abstract][Full Text] [Related]
4. The influence of the exocyclic amino group characteristic of GC base pairs on molecular recognition of specific nucleotide sequences in DNA by berenil and DAPI.
Waring MJ; Bailly C
J Mol Recognit; 1997; 10(3):121-7. PubMed ID: 9408827
[TBL] [Abstract][Full Text] [Related]
5. Berenil [1,3-bis(4'-amidinophenyl)triazene] binding to DNA duplexes and to a RNA duplex: evidence for both intercalative and minor groove binding properties.
Pilch DS; Kirolos MA; Liu X; Plum GE; Breslauer KJ
Biochemistry; 1995 Aug; 34(31):9962-76. PubMed ID: 7632695
[TBL] [Abstract][Full Text] [Related]
6. Comparison of binding sites in DNA for berenil, netropsin and distamycin. A footprinting study.
Portugal J; Waring MJ
Eur J Biochem; 1987 Sep; 167(2):281-9. PubMed ID: 3040405
[TBL] [Abstract][Full Text] [Related]
7. DNA-binding activity and cytotoxicity of Pt-berenil compounds in MDA-MB-231 and MCF-7 breast cancer cells.
Bielawski K; Bielawska A; Słodownik T; Popławska B; Bołkun-Skórnicka U
Acta Pol Pharm; 2008; 65(1):135-40. PubMed ID: 18536187
[TBL] [Abstract][Full Text] [Related]
8. Interaction of berenil with the tyrT DNA sequence studied by footprinting and molecular modelling. Implications for the design of sequence-specific DNA recognition agents.
Laughton CA; Jenkins TC; Fox KR; Neidle S
Nucleic Acids Res; 1990 Aug; 18(15):4479-88. PubMed ID: 2167469
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, DNA-binding affinity and cytotoxicity of the dinuclear platinum(II) complexes with berenil and amines ligands.
Bielawski K; Bielawska A; Popławska B; Bołkun-Skórnicka U
Acta Pol Pharm; 2008; 65(3):363-70. PubMed ID: 18646556
[TBL] [Abstract][Full Text] [Related]
10. Dinuclear berenil-platinum (II) complexes as modulators of apoptosis in human MCF-7 and MDA-MB231 breast cancer cells.
Agnieszka G; Ewa A; Anna B; Krzysztof B; Monika C; Elżbieta S
Anticancer Agents Med Chem; 2014; 14(8):1179-86. PubMed ID: 24954860
[TBL] [Abstract][Full Text] [Related]
11. The redox status of human breast cancer cell lines (MCF-7 and MDA-MB231) treated with novel dinuclear berenil-platinum(II) complexes.
Gęgotek A; Cyuńczyk M; Łuczaj W; Bielawska A; Bielawski K; Skrzydlewska E
Pharmazie; 2014 Dec; 69(12):923-8. PubMed ID: 25951667
[TBL] [Abstract][Full Text] [Related]
12. Netropsin, distamycin and berenil interact differentially with a high-affinity binding site for the high mobility group protein HMG-I.
Wegner M; Grummt F
Biochem Biophys Res Commun; 1990 Feb; 166(3):1110-7. PubMed ID: 2154972
[TBL] [Abstract][Full Text] [Related]
13. Deoxyribonuclease I footprinting reveals different DNA binding modes of bifunctional platinum complexes.
Chválová K; Kaspárková J; Farrell N; Brabec V
FEBS J; 2006 Aug; 273(15):3467-78. PubMed ID: 16824042
[TBL] [Abstract][Full Text] [Related]
14. The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG).
Lempers EL; Bloemink MJ; Brouwer J; Kidani Y; Reedijk J
J Inorg Biochem; 1990 Sep; 40(1):23-35. PubMed ID: 2283508
[TBL] [Abstract][Full Text] [Related]
15. Modification of the recognition of restriction sites of plasmid DNA by the antitumor drug Pt-pentamidine.
Pérez JM; González VM; Fuertes MA; Alonso C
Biochem Pharmacol; 1996 Sep; 52(6):851-6. PubMed ID: 8781502
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic efficacy of a novel dinuclear platinum(II) complex in human breast cancer cells.
Bielawska A; Popławska B; Surazyński A; Czarnomysy R; Bielawski K
Eur J Pharmacol; 2010 Sep; 643(1):34-41. PubMed ID: 20598681
[TBL] [Abstract][Full Text] [Related]
17. Dinuclear complexes of platinum having anticancer properties. DNA-binding studies and biological activity of bis(4,4'-dipyrazolylmethane-N,N')- bis[dichloroplatinum(II)] and related complexes.
Broomhead JA; Rendina LM; Webster LK
J Inorg Biochem; 1993 Feb; 49(3):221-34. PubMed ID: 8433090
[TBL] [Abstract][Full Text] [Related]
18. H-NMR studies on d(GCTTAAGC)2 and its complex with berenil.
Hu SH; Weisz K; James TL; Shafer RH
Eur J Biochem; 1992 Feb; 204(1):31-8. PubMed ID: 1740143
[TBL] [Abstract][Full Text] [Related]
19. Modulation of platinum antitumor drug binding to DNA by linked and free intercalators.
Bowler BE; Lippard SJ
Biochemistry; 1986 May; 25(10):3031-8. PubMed ID: 3718938
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous DNA binding modes of berenil.
Barceló F; Ortiz-Lombardía M; Portugal J
Biochim Biophys Acta; 2001 Jun; 1519(3):175-84. PubMed ID: 11418183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
